Cancer vaccine - AVI BioPharma

Drug Profile

Cancer vaccine - AVI BioPharma

Alternative Names: AVICINE; CTP 37

Latest Information Update: 15 Jan 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator AVI BioPharma
  • Class Cancer vaccines
  • Mechanism of Action Immunomodulators; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Colorectal cancer; Pancreatic cancer; Prostate cancer

Most Recent Events

  • 07 Mar 2005 Avicine® is still available for partnering (http://www.avibio.com)
  • 08 Sep 2003 No development reported - Phase-I for Prostate cancer in USA (IM)
  • 31 Mar 2003 Avicine® is available for partnering (http://www.avibio.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top